This guide is brought to you by Equifund, LLC.
If you’re here, you already know why you want to invest in Pre-IPO opportunities…
It’s a chance to get your money in on the “ground floor” and set yourself up for the biggest potential gains.
However, most investors don’t realize one important thing about Pre-IPO shares:
Once the company goes public, your shares don’t magically appear inside your brokerage account.
You – the investor – have to go through a non-trivial process of depositing your shares…
And sometimes, it’s not a easy, simple process.
That’s why we’ve put together this free report called How to Deposit Pre-IPO Shares Into Your Brokerage Account.
Inside, we’ll show you…
If you can’t get your Pre-IPO shares into your brokerage account, it could mean you miss out on any potential first-day “IPO-pop” you’ve heard so much about…
Or worse, not be able to sell out of your position at the price you want.
But don’t worry…
We’ll show you everything you need to know in this free, step-by-step report called How to Deposit Pre-IPO Shares Into Your Brokerage Account.
Yours for investing equality,
Jordan Gillissie – CEO
Equifund
On this call, Jake takes a deep dive into Pre-IPO investing, why you may want to consider investing in them, the mistakes investors make, and how Equifund looks at opportunities.
This past Thursday we sat down with Kurt Swogger, CEO and co-founder of Biopact CT for an in-depth interview. If you are a current investor in the company,
In this live “Open Office Hours” we preview our new Investment Policy Tool, talk deal analysis, and more.
For over a decade, Vcorp Services has delivered corporate products and services to attorneys, accountants, corporations and entrepreneurs. Tens of thousands have trusted Vcorp as their corporate compliance partner for commercial registered agent and document filing services. Vcorp’s distinguishing features include a robust team of service professionals, with deep understanding of the regulatory requirements and innovative right-sized technology.
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.
Over 20 patents have been issued to protect the company's technologies.
Just received FDA clearance for their next-generation KG2 spinal fusion technology.
The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO
Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:
We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.
Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.
If you have not received the email in 5 minutes, please click here to have it resent.
Questions? Our customer service team is always here to help – 1-866-338-3004
This content is for Equifund Members only.
Simply fill out the form below and get instant access:
Or sign-up using one of your existing social accounts…
